EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Ovarian and cervical cancer awareness: development of two validated measurement tools

Alice E Simon, Jane Wardle, Chloe Grimmett, Emily Power, Elizabeth Corker, Usha Menon, Lauren Matheson, Jo Waller

Journal of Family Planning and Reproductive Health Care · 2012-07 · 38 (3) · 167-174

DOI: 10.1136/jfprhc-2011-100118 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Family Planning and Reproductive Health Care, online erschienen am 20.09.2011. Verfasst von Alice E Simon und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Women's Health, University College London, London, UK. Hauptthemen laut MEDLINE: Awareness, Health Knowledge, Attitudes, Practice. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Cancer Research UK, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The aim of the study was to develop and validate measures of awareness of symptoms and risk factors for ovarian and cervical cancer (Ovarian and Cervical Cancer Awareness Measures).

Methods

Potentially relevant items were extracted from the literature and generated by experts. Four validation studies were carried out to establish reliability and validity. Women aged 21–67 years ( n =146) and ovarian and cervical cancer experts ( n =32) were included in the studies. Internal reliability was assessed psychometrically. Test-retest reliability was assessed over a 1-week interval. To establish construct validity, Cancer Awareness Measure (CAM) scores of cancer experts were compared with equally well-educated comparison groups. Sensitivity to change was tested by randomly assigning participants to read either a leaflet giving information about ovarian/cervical cancer or a leaflet with control information, and then completing the ovarian/cervical CAM.

Results

Internal reliability (Cronbach's α=0.88 for the ovarian CAM and α=0.84 for the cervical CAM) and test-retest reliability ( r =0.84 and r =0.77 for the ovarian and cervical CAMs, respectively) were both high. Validity was demonstrated with cancer experts achieving higher scores than controls [ovarian CAM: t (36)= –5.6, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AwarenessHealth Knowledge, Attitudes, PracticeAdultAgedAged, 80 and overEarly Detection of CancerFemaleHumansIncidenceMiddle AgedOvarian NeoplasmsPamphletsPsychometricsReproducibility of ResultsRisk FactorsUterine Cervical Neoplasms

Autor:innen und Institutionen

  • Institute of Women's Health, University College London, London, UK.

Förderung

  • Cancer Research UK
  • Medical Research Council

Zitieren

APA

Simon, A. E., Wardle, J., Grimmett, C., Power, E., Corker, E., Menon, U., Matheson, L., & Waller, J. (2012). Ovarian and cervical cancer awareness: development of two validated measurement tools. Journal of Family Planning and Reproductive Health Care, 38(3), 167-174. https://doi.org/10.1136/jfprhc-2011-100118

Vancouver

Simon AE, Wardle J, Grimmett C, Power E, Corker E, Menon U, et al. Ovarian and cervical cancer awareness: development of two validated measurement tools. Journal of Family Planning and Reproductive Health Care. 2012;38(3):167-174. doi:10.1136/jfprhc-2011-100118

BibTeX
@article{Simon2012,
  author = {Simon, Alice E and Wardle, Jane and Grimmett, Chloe and Power, Emily and Corker, Elizabeth and Menon, Usha and Matheson, Lauren and Waller, Jo},
  title = {Ovarian and cervical cancer awareness: development of two validated measurement tools},
  journal = {Journal of Family Planning and Reproductive Health Care},
  year = {2012},
  volume = {38},
  number = {3},
  pages = {167--174},
  doi = {10.1136/jfprhc-2011-100118}
}
Kostenlos starten →